Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 6,310 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Metabolism and Nutrition Disorders Clear all

Conditions: Adolescent Obesity
Interventions: Activity Tracker; Behavioral
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 12 Years to 18 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Breast Cancer
Interventions: Diabetes Prevention Program-based lifestyle change intervention (DPP), Highly Microbiota-Accessible Foods (HMAFs) intervention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 50 Years to 75 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obesity
Interventions: low vs high glycemic index diet; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Vitamin D Deficiency
Interventions: Placebo, 800 IU/day vitamin D supplementation with feedings in the first 28 days after birth, Usual Care; Dietary Supplement · Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 24 Hours to 96 Hours
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Infant,Premature, Body Weight, Adiposity
Interventions: Assessment of infant body composition; Diagnostic Test
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 1 Day to 14 Days
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Type 2 Diabetes, Obesity
Interventions: Tirzepatide, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 414 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 20
States / cities: Phoenix, Arizona • Concord, California • Sacramento, California + 17 more

Conditions: Obesity
Interventions: GSK2890457, Metformin, Placebo, Liraglutide; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 3
States / cities: Chula Vista, California • Miami, Florida • Overland Park, Kansas

Conditions: Spinal Cord Injury, Obesity
Interventions: Telenutrition Counseling; Behavioral
Lead sponsor: Santa Clara Valley Health & Hospital System; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Jose, California

Conditions: Vitamin D Deficiency, Insulin Resistance, Type 2 Diabetes Mellitus, Cardiovascular Disease, Hypertension
Interventions: Vitamin D3, Placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 25 Years to 80 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pediatric Disorder, Pediatric Obesity, Primary Hypertension
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 5 Years to 17 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Physical Activity, Childhood Obesity
Interventions: Treatment, Health Education; Behavioral · Other
Lead sponsor: University of South Carolina; Other
Eligibility: 11 Years to 16 Years
Enrollment: 330 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Columbia, South Carolina • Sumter, South Carolina

Conditions: Obesity, Hepatic Insufficiency
Interventions: CP-945,598; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 2
States / cities: Miami, Florida • Orlando, Florida

Conditions: Obesity &Amp; Overweight
Interventions: Freeze-dried grape powder, Placebo powder; Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Obesity, Osteoarthritis
Interventions: Not listed
Lead sponsor: Geisinger Clinic; Other
Eligibility: 22 Years to 75 Years
Enrollment: 289 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Overweight, Obesity
Interventions: Recommended Vegetable Intake, Usual Vegetable Intake; Other
Lead sponsor: USDA Grand Forks Human Nutrition Research Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Grand Forks, North Dakota

Conditions: Obese, Nondiabetic
Interventions: Weight loss; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years and older · Female only
Enrollment: 245 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Obesity
Interventions: barium sulfate tablet; Procedure
Lead sponsor: Saint Raphael Healthcare System; Other
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Healthy, no Evidence of Disease, Obesity, Weight Changes
Interventions: questionnaire administration, study of socioeconomic and demographic variables, survey administration, study of high risk factors; Other · Procedure
Lead sponsor: University of Southern California; Other
Eligibility: Not listed
Enrollment: 780 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Acute Lymphoblastic Leukemia, Obesity
Interventions: PEDALL, Standard of care; Behavioral · Other
Lead sponsor: Columbia University; Other
Eligibility: 5 Years to 21 Years
Enrollment: 376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Adrenal Insufficiency, Pituitary Neoplasm, Obesity
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 1,588 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Overweight, Obese
Interventions: Smartphone Application; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: Santa Monica, California

Conditions: Cardiovascular Diseases, Adiposity, Cardiometabolic Syndrome
Interventions: Chardonnay Marc; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 45 Years to 70 Years · Female only
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Davis, California

Conditions: Obesity, Overweight, Diabetes Mellitus, Type 2
Interventions: Naltrexone SR 32 mg/bupropion SR 360 mg/ day, Placebo, Ancillary therapy; Drug · Behavioral
Lead sponsor: Orexigen Therapeutics, Inc; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 505 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 53
States / cities: Fairhope, Alabama • Peoria, Arizona • Phoenix, Arizona + 46 more

Conditions: Obesity, Insulin Resistance, Metabolically Healthy Obesity, Obesity, Metabolically Benign
Interventions: People with Metabolically Unhealthy Obesity - Low Calorie Diet; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 25 Years to 55 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Interventions for Adolescent Obesity

UCLA Breast Cancer Survivor Health Promotion Research Study

Glycemic Index and CVD: a Crossover Feeding Study

Randomized Trial of Enteral Vitamin D Supplementation in Infants < 28 Weeks Gestational Age or <1000 Grams Birth Weight

Serial Assessment of Body Fat Accrual in Very Preterm Infants

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

Telenutrition in Spinal Cord Injury

Vitamin D, Insulin Resistance, and Cardiovascular Disease

Pediatric Primary Hypertension and the Renin-Angiotensin System (PHRAS)

The LEADS Trial (Linking Exericise for Advancing Daily Stress Management)

Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

Effects of Grape Consumption on the Immune-Gut Axis in Obesity

Surgical Weight-Loss to Improve Functional Status Trajectories Following Total Knee Arthroplasty (SWIFT Trial)

Motivating Value of Vegetables Study

Metabolism, Exercise and Nutrition at UCSD (MENU Study)

Measurement of Gastric Band Stoma Diameter

Study of a Smart Growth Community's Effect on Prevention of Obesity in Middle-, Moderately Low- and Low-Income Families

A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

Evaluation of Patients With Endocrine-Related Conditions

mFit: The Mobile Fitness Project

The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health

A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes

Small Extracellular Vesicles and Insulin Action